ATE361744T1 - Verwendung einer pharmazeutischen zusammensetzung enthaltend zwei quaternäre ammoniumverbindungen und eine organometal-verbindung zur behandlung von viralen und fungalen infekten und krankheiten - Google Patents

Verwendung einer pharmazeutischen zusammensetzung enthaltend zwei quaternäre ammoniumverbindungen und eine organometal-verbindung zur behandlung von viralen und fungalen infekten und krankheiten

Info

Publication number
ATE361744T1
ATE361744T1 AT01900955T AT01900955T ATE361744T1 AT E361744 T1 ATE361744 T1 AT E361744T1 AT 01900955 T AT01900955 T AT 01900955T AT 01900955 T AT01900955 T AT 01900955T AT E361744 T1 ATE361744 T1 AT E361744T1
Authority
AT
Austria
Prior art keywords
viral
diseases
pharmaceutical composition
fungal infections
treatment
Prior art date
Application number
AT01900955T
Other languages
German (de)
English (en)
Inventor
Mark Phillips
Original Assignee
Zetetic Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetetic Res Inc filed Critical Zetetic Res Inc
Application granted granted Critical
Publication of ATE361744T1 publication Critical patent/ATE361744T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/32—Tin compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT01900955T 2000-01-10 2001-01-09 Verwendung einer pharmazeutischen zusammensetzung enthaltend zwei quaternäre ammoniumverbindungen und eine organometal-verbindung zur behandlung von viralen und fungalen infekten und krankheiten ATE361744T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17531300P 2000-01-10 2000-01-10

Publications (1)

Publication Number Publication Date
ATE361744T1 true ATE361744T1 (de) 2007-06-15

Family

ID=22639801

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01900955T ATE361744T1 (de) 2000-01-10 2001-01-09 Verwendung einer pharmazeutischen zusammensetzung enthaltend zwei quaternäre ammoniumverbindungen und eine organometal-verbindung zur behandlung von viralen und fungalen infekten und krankheiten

Country Status (7)

Country Link
US (2) US6420421B1 (fr)
EP (1) EP1408941B1 (fr)
AT (1) ATE361744T1 (fr)
AU (1) AU2001226361A1 (fr)
CA (1) CA2396368A1 (fr)
DE (1) DE60128407T2 (fr)
WO (1) WO2001051603A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0010700A (pt) * 1999-04-30 2002-02-13 Slil Biomedical Corp Conjugados análogos de poliamina e conjugados de quinona como terapias para cânceres e doenças na próstata
HK1040993B (en) * 1999-04-30 2006-11-10 Cellgate, Inc. Polyamines and their use in therapy
AU2002235126A1 (en) * 2000-11-08 2002-05-21 Slil Biomedical Corporation Novel polyamine analog-amino acid conjugates useful as anticancer agents
EP1436246A1 (fr) * 2001-10-16 2004-07-14 SLIL Biomedical Corporation Composes oligoamine et leurs derives pour le traitement des cancers
FR2890565A1 (fr) * 2005-09-12 2007-03-16 Laurent Roger Thierry Clerc Procedes et composition d'une formulation inedite pour le traitement de maladies infectieuses chez l'homme ou l'animal
WO2011066006A2 (fr) * 2009-08-19 2011-06-03 Abukurah Abdul R Méthodes de traitement du sida
EP3755368A4 (fr) * 2018-02-23 2021-12-22 The Administrators of The Tulane Educational Fund Composition pharmaceutique pour infections virales

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3594468A (en) 1969-04-01 1971-07-20 Vincent R Saurino Germicidal compositions
US4021537A (en) * 1973-08-09 1977-05-03 Research Lab Products, Inc. Oral bactericidal compositions
US4343815A (en) 1973-08-30 1982-08-10 M&T Chemicals Inc. Method for combating fungi and mites using certain triorganotin compounds
GB1476862A (en) * 1974-11-13 1977-06-16 Rossmore H Antimicrobial compositions and methods
US4204954A (en) 1978-08-01 1980-05-27 Chemed Corporation Detoxification of residual quaternaries
US4321277A (en) 1978-12-04 1982-03-23 Research Lab Products, Inc. Germicidal use of compositions containing certain quaternary ammonium compounds
US4263278A (en) 1979-07-10 1981-04-21 Saurino Vincent R Mortuary composition
US4283421A (en) * 1979-12-19 1981-08-11 Ray Frank F Anti-viral treatment
US4464398A (en) 1981-08-11 1984-08-07 Huntington Laboratories, Inc. Germicide and an improved method for killing bacteria, fungus and/or viruses
US4902720A (en) 1983-01-10 1990-02-20 Baldone Joseph A Treatment of virus infections with quaternary ammonium compounds
US4797420A (en) 1984-08-14 1989-01-10 Jabco Manufacturing, Inc. Disinfectant formulation and method of use
DE3516695A1 (de) 1985-05-09 1986-11-13 Schering AG, 1000 Berlin und 4709 Bergkamen Biozide tributylzinnverbindungen
DK156159C (da) 1986-04-10 1989-11-27 Gori As Fremgangsmaade til stabilisering af tributyltin-fungicider til traebeskyttelse
US4732911A (en) 1987-03-13 1988-03-22 Betz Laboratories, Inc. Biocidal compositions and use thereof containing a synergistic mixture of 2-bromo-2-nitropropane-1,3-diol and bis (tri n-butyl tin) oxide
US4928629A (en) 1988-06-13 1990-05-29 Iowa State University Research Foundation, Inc. Egg inoculation method
US4914132A (en) 1989-05-25 1990-04-03 Betz Laboratories, Inc. Biocidal compositions and use thereof containing a synergistic mixute of 2-(decylthio)ethanamine hydrochloride and n-alkyl dimethyl benzyl ammonium chloride
US4998984A (en) 1989-11-15 1991-03-12 Mcclendon Evelyn Premoistened prepackaged disposable disinfectant wiper
WO1993018745A1 (fr) * 1992-03-23 1993-09-30 Geda International S.A. Utilisation d'un revetement antiviral avec des articles en latex tels que les preservatifs
US5169536A (en) 1992-04-28 1992-12-08 Betz Laboratories, Inc. Detoxification agents for surfactant based biocides
US5336305A (en) 1993-07-06 1994-08-09 International Laboratory Technology Corp. Flexible material having barrier properties
US5417968A (en) 1993-08-16 1995-05-23 International Laboratory Technology Corp. Antimicrobial barrier composition
US5444094A (en) 1993-08-24 1995-08-22 Stepan Company Methods and compositions for disinfecting surfaces containing tuberculosis causing bacteria
US5611938A (en) 1995-02-28 1997-03-18 Ashland Inc. Biocidal blends of quaternary ammonium compounds and chlorine dioxide
US5698207A (en) 1995-07-26 1997-12-16 International Laboratory Technology Corp. Burn treatment composition

Also Published As

Publication number Publication date
EP1408941A4 (fr) 2006-01-25
DE60128407T2 (de) 2008-01-10
EP1408941A2 (fr) 2004-04-21
DE60128407D1 (de) 2007-06-21
US20020061926A1 (en) 2002-05-23
US6462079B2 (en) 2002-10-08
WO2001051603A2 (fr) 2001-07-19
US6420421B1 (en) 2002-07-16
EP1408941B1 (fr) 2007-05-09
CA2396368A1 (fr) 2001-07-19
WO2001051603A3 (fr) 2001-12-13
AU2001226361A1 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
DE60031396D1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
ATE487493T1 (de) Azolsäure-derivate, allein oder kombiniert, zur behandlung von diabetes und dyslipidaemien; und zur behandlung von malignen erkrankungen
DE69925256D1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
DE69823344D1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
ATE309794T1 (de) Methode zur hemmung des wachstums von bakterien oder pilzen mit einem komplexbildner
DE69422450D1 (de) Chinoline oder Chinazolin-Derivate und deren Verwendung zur Herstellung eines Medikaments für die Behandlung von Osteoporose
EP1001782A4 (fr) 5,6-HETEROARYL-DIPYRIDO 2,3-$i(b):3',2'-$i(f)]AZEPINES ET LEUR UTILISATION DANS LA PREVENTION OU LE TRAITEMENT DE L'INFECTION PAR LE VIH
ATE163645T1 (de) Eintopfverfahren zur herstellung von 3- chinoloncarbonsäurederivaten
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
DK0604183T3 (da) HIV-protease-inhibitorer anvendelige i behandlingen af AIDS
EE200300504A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
DE60218843D1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
ATE361744T1 (de) Verwendung einer pharmazeutischen zusammensetzung enthaltend zwei quaternäre ammoniumverbindungen und eine organometal-verbindung zur behandlung von viralen und fungalen infekten und krankheiten
TR200101841T2 (tr) Enfeksiyonlardan korunmak ve enfeksiyon tedavisi için bifosfonatların kullanılmaları
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
DE69307674D1 (de) HIV-Proteaseinhibitoren und ihre Verwendung zur Behandlung von AIDS
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
ATE294584T1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
DE50011645D1 (de) Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
EE200300495A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE145828T1 (de) Verfahren zur desinfektion von muskelskelettgeweben und so aufbereitete gewebe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1408941

Country of ref document: EP

REN Ceased due to non-payment of the annual fee